ARCHIVES

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

This article is from The Cancer Letter archive.

Vol. 09 No. 45 | November 25, 1983

Download PDF Visit The Full Archive

Related Articles

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011